Theravance Biopharma TBPH
NASDAQ TBPH
$17.03 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Theravance Biopharma (TBPH) Property, Plant & Equipment (Net) (2013 - 2026)

Updated

Theravance Biopharma (TBPH) posted Property, Plant & Equipment (Net) of $5.17 million for Q2 2026, down 22.2% from $6.64 million a year earlier and down 6.7% from the prior quarter.

Analysis

Theravance Biopharma (TBPH) Property, Plant & Equipment (Net) (2013 - 2026) Analysis & Trends

At the end of FY2025, Theravance Biopharma's Property, Plant & Equipment (Net) came in at $5.9 million, down 20.5% from FY2024.

  • Annual Property, Plant & Equipment (Net) has declined for five consecutive years, with a five-year compound annual growth rate of -18.5% (FY2020 to FY2025).
  • In prior years, Theravance Biopharma's Property, Plant & Equipment (Net) was $7.42 million in FY2024 (-18.2%), $9.07 million in FY2023 (-23.6%), $11.88 million in FY2022 (-13.0%) and $13.66 million in FY2021 (-16.8%).
  • The Q2 2026 figure stands as the lowest quarterly Property, Plant & Equipment (Net) in data going back to Q4 2013.
  • On a year-over-year basis, Property, Plant & Equipment (Net) has declined in each of the last 19 quarters, with an average decline of 19.5% over the last eight quarters.
  • The strongest year-over-year quarter for Property, Plant & Equipment (Net) in the past five years was Q3 2021, with growth of 3.7%; the weakest was Q1 2024, with a decline of 28.0%.
  • According to Business Quant data, Property, Plant & Equipment (Net) for the three prior quarters was $5.54 million (Q1 2026), $5.9 million (Q4 2025) and $6.26 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 29.29 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 23.58 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 5.80 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 25.74 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 10.69 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 13.62 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 8.55 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 5.83 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 19.03 Bn
10 Theravance Biopharma 883.70 Mn -543.66 Mn - 5.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.17 Mn
Mar 31, 2026 5.54 Mn
Dec 31, 2025 5.90 Mn
Sep 30, 2025 6.26 Mn
Jun 30, 2025 6.64 Mn
Mar 31, 2025 7.03 Mn
Dec 31, 2024 7.42 Mn
Sep 30, 2024 7.79 Mn
Jun 30, 2024 8.14 Mn
Mar 31, 2024 8.72 Mn
Dec 31, 2023 9.07 Mn
Sep 30, 2023 9.29 Mn
Jun 30, 2023 9.55 Mn
Mar 31, 2023 12.10 Mn
Dec 31, 2022 11.88 Mn
Sep 30, 2022 11.88 Mn
Jun 30, 2022 12.53 Mn
Mar 31, 2022 13.24 Mn
Dec 31, 2021 13.66 Mn
Sep 30, 2021 16.00 Mn
API Access

Theravance Biopharma Property, Plant & Equipment (Net) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=TBPH&period=max&api_key=YOUR_API_KEY